Target Tissue Identification through the detection
of Intrinsic Biomolecular Markers using
Multispectral Autofluorescence Imaging

Target Tissue Identification through the detection of Intrinsic Biomolecular Markers using
Multispectral Autofluorescence Imaging.

STEP 1

Multi-Spectral Illumination

STEP 2

Multi-Spectral Detection

STEP 3

Train AI/ML Algorithms

CytoVeris’ UV-Excited Tissue Autofluoresence Imaging allows the differentiation of tissue types & structures

Validated our Technology Platform

Validated our Technology Platform

Trained on Ground Truth Data using LOPO

Tested using 5-Fold Cross Validation Data Sets

Patient = 92
Specimen Blocks = 139
Targets = 473

SENSITIVITY = 90.6%
SPECIFICITY = 89.9%
ACCURACY = 90.1%

Real-time imaging during prostatectomy could improve the odds of preservation of function and reduce recurrence for 90,000 men in the U.S. per year.

60% reduction in the breast cancer positive margin rate nationwide could avoid reoperations for 30,000 women annually.

Real-time bladder resection imaging could avoid 70,000 repeat TURBT procedures per year in the U.S.


Real-time imaging during prostatectomy could improve the odds of preservation of function and reduce recurrence for 90,000 men in the U.S. per year.


60% reduction in the breast cancer positive margin rate nationwide could avoid reoperations for 30,000 women annually.


Real-time bladder resection imaging could avoid 70,000 repeat TURBT procedures per year in the U.S.

Learn More about CytoVeris’ AURORA™ technology.

Learn More about CytoVeris’ Technology and Products

// Investor Login